BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24824027)

  • 1. Cyclin A predicts metastatic potential of rectal neuroendocrine tumors.
    Jernman J; Välimäki MJ; Hagström J; Louhimo J; Haapasalo H; Arola J; Haglund C
    Hum Pathol; 2014 Aug; 45(8):1605-9. PubMed ID: 24824027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
    Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
    Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.
    Jernman J; Hagström J; Mäenpää H; Välimäki MJ; Haapasalo H; Nilsson O; Fermér C; Haglund C; Arola J
    Anticancer Res; 2015 Jul; 35(7):3767-72. PubMed ID: 26124320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
    Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
    Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors?
    Sugimoto S; Hotta K; Shimoda T; Imai K; Ito S; Yamaguchi Y; Takizawa K; Kakushima N; Tanaka M; Kawata N; Yoshida M; Ishiwatari H; Matsubayashi H; Ono H
    Dig Dis; 2018; 36(2):118-122. PubMed ID: 29130971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
    Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
    Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
    Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
    Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy.
    Lee SH; Kim BC; Chang HJ; Sohn DK; Han KS; Hong CW; Lee EJ; Lee JB; Lee DS; Lee IT; Youk EG
    Am J Surg Pathol; 2013 Jul; 37(7):1044-52. PubMed ID: 23648459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.
    Kim GU; Kim KJ; Hong SM; Yu ES; Yang DH; Jung KW; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
    Endoscopy; 2013 Dec; 45(12):1018-23. PubMed ID: 24288222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
    Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.